Samsung Bioepis, a subsidiary of Samsung Biologics, has surpassed 1 trillion won ($748.5 million) in annual sales since it was founded 12 years ago.According to the 2023 earnings report released by the company on Wednesday, Samsung Bioepis posted annualized sales of 1.02 trillion won and operating i
Narcolepsy is a rare and much-misunderstood disease with an estimated prevalence of 15 per 100,000 Koreans. It's a "brain disease" caused by a lack of hypocretin, a wakefulness hormone secreted by the brain, but most people are not aware of it. There is also a common misconception that narcolepsy mu
In recent years, the paradigm of hypertension treatment has shifted toward aggressive blood pressure management to prevent serious cardiovascular complications. This shift has led to the growing importance of combination therapy in treating hypertension. Combination therapy has the advantage of prov
Bristol Myers Squibb (BMS) Korea presented a patient-specific treatment, utilizing its psoriasis drug, Sotyktu (deucravacitinib), in a media session in Seoul on Thursday. Psoriasis is a chronic, non-infectious skin disease with repeated flare-ups and remissions.According to Bang Chul-hwan, professor
The Ministry of Trade, Industry and Energy (MOTIE) revealed on Thursday its commitment to allocate a total budget of 266 billion won ($199 million) for bio research and development (R&D) this year.In 2024, the ministry's focus will be on advancing biopharmaceuticals, including innovative new drugs,
Theragen Health, a subsidiary of Lotte Healthcare, said it has recently opened a new microbiome lab in Pankyo in Seongnam, Gyeonggi Province, significantly expanding its capabilities in the field of microbial analysis.The laboratory is equipped to handle up to 100,000 DNA samples annually.The microb
The Minister of Health and Welfare, Cho Kyoo-hong, highlighted the necessity of augmenting the medical school enrollment quota in Korea during the health ministers’ meeting of the Organization for Economic Cooperation and Development (OECD).The Ministry of Health and Welfare said Cho attended the OE
CHA Vaccine Institute, a Kosdaq-listed vaccine development company, said Thursday that it has developed Lipoplex, a messenger ribonucleic acid (mRNA) delivery system using adjuvants.Medicines utilizing mRNA have gained prominence since the Covid-19 pandemic. The advantage of mRNA vaccines and therap
Researchers at the Korea Advanced Institute of Science and Technology (KAIST) have manufactured a novel bio-scaffold that exhibits electrical signals when pressure is applied, accelerating bone regeneration.Bone healing is complex, and conventional methods like bone grafting and growth factor delive
RecensMedical, a medical device developer, said Thursday that it had signed a business agreement with LG Chem to market TargetCool, a rapid cooling medical device, in China.The agreement is a further expansion of the previous accord signed in 2022, further strengthening their collaboration to expand
The Korean Health Industry Development Institute (KHIDI) said it has started accepting applications from Korean healthcare companies that want to move into its Boston Connect and Development (C&D) Incubation Office, located within the Cambridge Innovation Center (CIC) in Boston, Mass. KHIDI will acc
Samsung Biologics on Wednesday reported last year’s consolidated sales of 3.69 trillion won ($2.76 billion) and operating profit of 1.11 trillion won.This represents a 23.1 percent year-on-year increase in sales and a 13.2 percent increase in operating profit compared to those in 2022.It is the firs
NKMAX's stock price has plummeted overnight, raising questions in the market. However, the company hurriedly tried to calm down the jitters, saying there were “no internal issues.”On Wednesday morning, NKMAX’s stock price fell by 29.87 percent, or 1,550 won ($1.15), to 3,640 won from the previous da
PharmAbcine said Wednesday that the company began the administration of its VISTA-targeted immunotherapy candidate, PMC-309, in patients in Australia.The Australian phase 1a/b trial will be conducted on 67 patients with advanced or metastatic solid tumors at four medical institutions.According to Ph
Researchers at the Korea Research Institute of Bioscience & Biotechnology (KRIBB) have successfully developed a gene therapy for hereditary spastic paraplegia (HSP), a rare, incurable disorder.HSP, a genetic neurological condition, leads to progressive stiffness and weakness in the legs, eventually
AriBio has entered into a comprehensive collaboration with Vietnam's state-owned Central Pharmaceutical Joint Stock Company (CPC1) to sell and distribute AR1001, an oral dementia treatment candidate.The Korean company said Wednesday that it would also collaborate with OPC Pharma on developing natura
Asan Medical Center (AMC) takes the most proactive approach to deal with the aging of hospitalized patients.In September 2020, AMC recognized the need to address the needs of elderly patients through continuous discussions after medical professionals who had frequent contact with them voluntarily fo
To raise the renown of K-medical, Korean hospitals are actively working to attract international patients.In line with this trend, the International Medical Center under CHA Bundang Medical Center, in Bundang, Gyeonggi Province, has expanded and renamed itself as "CHA Global Hospital," transforming
As the healthcare investment landscape undergoes rapid transformation in 2024, industry experts highlight emerging trends and strategic approaches to capitalizing on these changes.The focus is particularly on the increasing prominence of GLP-1 drugs in obesity treatment, significant mergers and acqu
JW Shinyak, a Kosdaq-listed biotech company, said Wednesday that it has started selling Ducray Neoptide Expert, Pierre Fabre’s hair loss relief cosmetic.Ducray Neoptide Expert is a specialized cosmetic for hair loss relief developed through clinical trials and is available at medical institutes for